NCT03706157View on ClinicalTrials.gov

Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Hepato Cellular Carcinoma
Interventions
DRUG

Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc iso-osmolar ionic iodinated contrast media

Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc iso-osmolar ionic iodinated contrast media

DRUG

Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc normal saline

Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc normal saline

Trial Locations (1)

67000

University Hospital, Strasbourg, france, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT03706157 - Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE | Biotech Hunter | Biotech Hunter